Effect of Dapagliflozin in Patients with Heart Failure: A Systematic Review and Meta-Analysis

BACKGROUND: Heart failure (HF) is a major cause of recurrent hospitalization and death worldwide. Sodium-glucose cotransporter-2 inhibitors including dapagliflozin are anti-diabetic drugs with promising cardiovascular (CV) effects. We performed systematic review and meta-analysis of randomized contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ahmed E., Mazroua, Muhammad Sabry, ElSaban, Mariam, Najam, Nadia, Kothari, Aditi S., Mansoor, Taha, Amal, Tanya, Lee, Joanna, Kashyap, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453961/
https://www.ncbi.nlm.nih.gov/pubmed/37636033
http://dx.doi.org/10.5334/gh.1258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453961/
https://www.ncbi.nlm.nih.gov/pubmed/37636033
http://dx.doi.org/10.5334/gh.1258

Ejemplares similares